The role of passive immunization in the age of SARS-CoV-2: an update release_ryyjmk5e6jfbrbq4dsdffq5xee

by Johannes C. Fischer, Kurt Zänker, Martijn van Griensven, Marion Schneider, Detlef Kindgen-Milles, Wolfram Trudo Knoefel, Artur Lichtenberg, Balint Tamaskovics, Freddy Joel Djiepmo-Njanang, Wilfried Budach, Stefanie Corradini, Ute Ganswindt (+8 others)

Published in European Journal of Medical Research by Springer Science and Business Media LLC.

2020   Volume 25, Issue 1, p16

Abstract

The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-2 virus. In this review, we describe the role of passive immunization in times of the corona virus. Passive immunization could be a bridging technology to improve the immune defense of critically ill patients until better approaches with effective medications are available.
In text/plain format

Archived Files and Locations

application/pdf  1.1 MB
file_h2p3iuc5zvearnvia324kbqxt4
eurjmedres.biomedcentral.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2020-05-13
Language   en ?
Journal Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:  0949-2321
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 381e5b03-0167-4801-ab2a-ec954fbe9bb6
API URL: JSON